AG 2000

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 591340

CAS#: 111712-16-4

Description: AG 2000 is a biochemical.

Chemical Structure

img
AG 2000
CAS# 111712-16-4
Instruction

Theoretical Analysis

MedKoo Cat#: 591340
Name: AG 2000
CAS#: 111712-16-4
Chemical Formula: C16H13BF7N3OS
Exact Mass: 439.08
Molecular Weight: 439.160
Elemental Analysis: C, 43.76; H, 2.98; B, 2.46; F, 30.28; N, 9.57; O, 3.64; S, 7.30

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: AG 2000; AG-2000; AG2000;

IUPAC/Chemical Name: 5H-Pyrido(1',2':4,5)(1,2,4)thiadiazino(2,3-a)benzimidazol-13-ium, 4-methyl-3-(2,2,2-trifluoroethoxy)-, tetrafluoroborate(1-)

InChi Key: IXVZBEYWFWRNJA-UHFFFAOYSA-N

InChi Code: InChI=1S/C16H13F3N3OS.BF4/c1-10-13-8-24-22-12-5-3-2-4-11(12)20-15(22)21(13)7-6-14(10)23-9-16(17,18)19;2-1(3,4)5/h2-7H,8-9H2,1H3;/q+1;-1

SMILES Code: FC(F)(F)COC1=CC=[N+](C2=NC3=CC=CC=C3N2SC4)C4=C1C.F[B-](F)(F)F

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 439.16 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Chang YD, Smith J, Portman D, Kim R, Oberoi-Jassal R, Rajasekhara S, Davis M. Single Institute Experience With Methylphenidate and American Ginseng in Cancer-Related Fatigue. Am J Hosp Palliat Care. 2018 Jan;35(1):144-150. doi: 10.1177/1049909117695733. Epub 2017 Mar 16. PubMed PMID: 28299946.

2: Biswas SK, Yokoyama K, Kamei K, Nishimura K, Miyaji M. Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor. Med Mycol. 2001 Jun;39(3):283-5. PubMed PMID: 11446532.

3: Schmarda A, Dinkhauser P, Gschwentner M, Ritter M, Fürst J, Scandella E, Wöll E, Laich A, Rossmann H, Seidler U, Lang F, Paulmichl M. The gastric H,K-ATPase blocker lansoprazole is an inhibitor of chloride channels. Br J Pharmacol. 2000 Feb;129(3):598-604. PubMed PMID: 10711360; PubMed Central PMCID: PMC1571856.

4: Ohta T, Tajima H, Yachie A, Yokoyama K, Elnemr A, Fushida S, Kitagawa H, Kayahara M, Nishimura G, Miwa K, Yamamoto M, Terada T, Ohkuma S. Activated lansoprazole inhibits cancer cell adhesion to extracellular matrix components. Int J Oncol. 1999 Jul;15(1):33-9. PubMed PMID: 10375591.

5: Nagata K, Takagi E, Satoh H, Okamura H, Tamura T. Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum. Antimicrob Agents Chemother. 1995 Oct;39(10):2187-92. PubMed PMID: 8619564; PubMed Central PMCID: PMC162911.

6: Tsuchiya M, Imamura L, Park JB, Kobashi K. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor. Biol Pharm Bull. 1995 Aug;18(8):1053-6. PubMed PMID: 8535394.

7: Bando T, Kasahara K, Shibata K, Numata Y, Nakatsumi Y, Fujimura M, Matsuda T. Role of sodium pump systems to determine sensitivity to mitomycin C in non-small cell lung cancer cell lines. Anticancer Res. 1995 May-Jun;15(3):769-72. PubMed PMID: 7645956.

8: Nagata K, Takagi E, Tsuda M, Nakazawa T, Satoh H, Nakao M, Okamura H, Tamura T. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease. Antimicrob Agents Chemother. 1995 Feb;39(2):567-70. PubMed PMID: 7726537; PubMed Central PMCID: PMC162584.

9: Nakajima N, Kuwayama H, Iwasaki A, Arakawa Y. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth. J Clin Gastroenterol. 1995;20 Suppl 2:S90-2. PubMed PMID: 7594352.

10: Bando T, Kasahara K, Shibata K, Nakatsumi Y, Fujimura M, Matsuda T. Effect of proton pump inhibitor on cell growth and sensitivity to cis-diamminedichloroplatinum(II) in non-small cell lung cancer cell lines. Anticancer Res. 1994 Nov-Dec;14(6B):2727-30. PubMed PMID: 7872708.

11: Nagata K, Satoh H, Iwahi T, Shimoyama T, Tamura T. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrob Agents Chemother. 1993 Apr;37(4):769-74. PubMed PMID: 8494373; PubMed Central PMCID: PMC187756.

12: Iwahi T, Satoh H, Nakao M, Iwasaki T, Yamazaki T, Kubo K, Tamura T, Imada A. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother. 1991 Mar;35(3):490-6. PubMed PMID: 2039199; PubMed Central PMCID: PMC245037.

13: Nagaya H, Satoh H, Maki Y. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells. J Pharmacol Exp Ther. 1990 Mar;252(3):1289-95. PubMed PMID: 2156997.

14: Nagaya H, Satoh H, Kubo K, Maki Y. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749. J Pharmacol Exp Ther. 1989 Feb;248(2):799-805. PubMed PMID: 2537417.